Alkermes Plc (ALKS) support and resistance · P/E 14, rev $1.56B
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
This page maps Alkermes Plc (ALKS) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new ALKS 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the ALKS quote page for the session range and the stock page for the full model.
Not investment advice.